L
LEGN
Legend Biotech Corp
29.37
+1.38+4.93%Pre Market: 29.76 +0.39 +1.34%04:31 05/26 EDT
OPEN/PREV CLOSE27.50/27.99
TODAY RANGE27.19-30.10
VOL102
MARKET CAP5.46B
52 WEEK RANGE16.24-45.30
AVG VOL (3M)2.04M
% TURNOVER1.10%
TURNOVER0
P/E (TTM)-21.6577
% RANGE10.38%
EPS(TTM)-1.3561
P/E(FORWARD)-41.9571
P/B3.228
BVPS5.42
DIVIDEND--
P/S3.144
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.35B
SHARES OUTSTANDING185.74M
NEXT EARNINGS08/10-08/14
FREE FLOAT182.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Legend Biotech (LEGN) Is Up 6.6% After Strong Q1 And New CAR-T Data Release - Has The Bull Case Changed?
Simply Wall St·4d ago
A Look At Legend Biotech (LEGN) Valuation After Its Strong Q1 2026 Revenue And Narrower Net Loss
TipRanks·4d ago
Legend Biotech to Showcase New CAR-T Data at ASCO 2026
Seeking Alpha·4d ago
Why Gilead Sciences Is Now A Hold (Rating Upgrade)
Dow Jones·05/18 11:22
Legend Biotech Price Target Maintained With a $50.00/Share by HC Wainwright & Co.
Benzinga·05/18 11:11
HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $50 Price Target
Simply Wall St·05/17 00:25
How Investors Are Reacting To Legend Biotech (LEGN) Carvykti-Fueled Revenue Surge And Narrowing Losses
TipRanks·05/15 21:28
3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
Simply Wall St·05/14 01:46
Legend Biotech (LEGN) Q1 Loss Persists And Tests Bullish Profitability Narratives
Benzinga·05/13 18:07
These Analysts Revise Their Forecasts On Legend Biotech After Q1 Results
Dow Jones·05/13 17:31
Legend Biotech Price Target Raised to $29.00/Share From $21.00 by TD Cowen
Dow Jones·05/13 17:31
Legend Biotech Is Maintained at Hold by TD Cowen
Benzinga·05/13 17:21
TD Cowen Maintains Hold on Legend Biotech, Raises Price Target to $29